Letter from the White House dated July 31, 2025, addressed to Robert Michael at AbbVie. The letter discusses an executive order on "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients" aimed at reducing drug prices in the U.S. The letter outlines specific actions expected from drug manufacturers, including extending Most-Favored-Nation (MFN) pricing to Medicaid, guaranteeing MFN pricing for new drugs, and returning increased revenues to American patients. The letter emphasizes the need for immediate action to lower drug prices. The letter is signed at the bottom.